rapilysin
actavis group ptc ehf - reteplázzal - miokardiális infarktus - antitrombotikus szerek - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
spevigo
boehringer ingelheim international gmbh - spesolimab - pikkelysömör - immunszuppresszánsok - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - pikkelysömör - immunszuppresszánsok - treatment of moderate-to-severe plaque psoriasis in adults.
vancomycin hikma 500 mg por oldatos infúzióhoz
hikma farmaceutica sa - vankomicin -
vancomycin hikma 1000 mg por oldatos infúzióhoz
hikma farmaceutica sa - vankomicin -
quetiapine-teva 50 mg retard tabletta
teva gyógyszergyár zrt. - quetiapine -
quetiapine-teva 150 mg retard tabletta
teva gyógyszergyár zrt. - quetiapine -
quetiapine-teva 200 mg retard tabletta
teva gyógyszergyár zrt. - quetiapine -
quetiapine-teva 300 mg retard tabletta
teva gyógyszergyár zrt. - quetiapine -
quetiapine-teva 400 mg retard tabletta
teva gyógyszergyár zrt. - quetiapine -